[ad_1]
(MENAFN – NewsBytes) In a major development, Bharat Biotech has announced that its homegrown COVID-19 vaccine candidate, COVAXIN, has been proven effective in animal trials.
The injection, the company says, has been able to elicit a strong immune response against the new coronavirus in a live viral challenge model involving primates.
This is all you need to know about it.
Trial 20 primates tested with placebo and COVAXIN
MENAFN1209202001650000ID1100785775
Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, integrity, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this item, please contact the provider listed above.
